Signet Financial Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.38M | Sell |
24,722
-488
| -2% | -$108K | 0.6% | 51 |
|
|
2025
Q4 | $5.76M | Buy |
25,210
+116
| +0.5% | +$26.4K | 0.64% | 47 |
|
|
2025
Q3 | $5.81M | Sell |
25,094
-16,186
| -39% | -$3.3M | 0.67% | 41 |
|
|
2025
Q2 | $7.66M | Sell |
41,280
-154
| -0.4% | -$28.6K | 0.96% | 24 |
|
|
2025
Q1 | $8.68M | Buy |
41,434
+138
| +0.3% | +$26.8K | 1.17% | 17 |
|
|
2024
Q4 | $7.34M | Sell |
41,296
-951
| -2% | -$175K | 0.94% | 26 |
|
|
2024
Q3 | $8.34M | Sell |
42,247
-294
| -0.7% | -$54.9K | 1.06% | 23 |
|
|
2024
Q2 | $7.3M | Sell |
42,541
-123
| -0.3% | -$20.4K | 0.98% | 25 |
|
|
2024
Q1 | $7.77M | Buy |
42,664
+128
| +0.3% | +$22.1K | 1.07% | 21 |
|
|
2023
Q4 | $6.59M | Sell |
42,536
-130
| -0.3% | -$19K | 0.99% | 21 |
|
|
2023
Q3 | $6.36M | Sell |
42,666
-1,817
| -4% | -$267K | 1.05% | 18 |
|
|
2023
Q2 | $5.99M | Sell |
44,483
-1,038
| -2% | -$152K | 0.95% | 20 |
|
|
2023
Q1 | $7.25M | Sell |
45,521
-233
| -0.5% | -$35.6K | 1.22% | 12 |
|
|
2022
Q4 | $7.39M | Sell |
45,754
-307
| -0.7% | -$47.1K | 1.32% | 14 |
|
|
2022
Q3 | $6.18M | Buy |
46,061
+254
| +0.6% | +$36.4K | 1.21% | 15 |
|
|
2022
Q2 | $7.02M | Buy |
45,807
+30
| +0.1% | +$4.58K | 1.34% | 12 |
|
|
2022
Q1 | $7.42M | Sell |
45,777
-189
| -0.4% | -$27.5K | 1.24% | 15 |
|
|
2021
Q4 | $6.22M | Buy |
45,966
+299
| +0.7% | +$35.3K | 0.94% | 21 |
|
|
2021
Q3 | $4.93M | Sell |
45,667
-44
| -0.1% | -$5.03K | 0.85% | 30 |
|
|
2021
Q2 | $5.15M | Sell |
45,711
-158
| -0.3% | -$17.8K | 1.76% | 16 |
|
|
2021
Q1 | $4.96M | Sell |
45,869
-1,429
| -3% | -$153K | 0.93% | 28 |
|
|
2020
Q4 | $5.07M | Sell |
47,298
-1,051
| -2% | -$101K | 1.02% | 24 |
|
|
2020
Q3 | $4.57M | Sell |
48,349
-3,083
| -6% | -$290K | 1.01% | 23 |
|
|
2020
Q2 | $4.75M | Sell |
51,432
-13,264
| -21% | -$1.17M | 1.06% | 23 |
|
|
2020
Q1 | $5.85M | Sell |
64,696
-5,800
| -8% | -$494K | 1.38% | 15 |
|
|
2019
Q4 | $6.24M | Sell |
70,496
-1,340
| -2% | -$111K | 1.17% | 20 |
|
|
2019
Q3 | $6.15M | Sell |
71,836
-2,735
| -4% | -$188K | 1.2% | 21 |
|
|
2019
Q2 | $5.05M | Sell |
74,571
-6,289
| -8% | -$494K | 1% | 31 |
|
|
2019
Q1 | $6.34M | Sell |
80,860
-6,861
| -8% | -$561K | 1.24% | 18 |
|
|
2018
Q4 | $8.09M | Sell |
87,721
-3,711
| -4% | -$326K | 1.76% | 5 |
|
|
2018
Q3 | $8.65M | Sell |
91,432
-4,205
| -4% | -$399K | 1.51% | 10 |
|
|
2018
Q2 | $8.86M | Sell |
95,637
-1,004
| -1% | -$98.1K | 1.56% | 8 |
|
|
2018
Q1 | $9.15M | Buy |
96,641
+702
| +0.7% | +$77.1K | 1.64% | 9 |
|
|
2017
Q4 | $9.28M | Sell |
95,939
-1,401
| -1% | -$132K | 1.73% | 8 |
|
|
2017
Q3 | $8.65M | Buy |
97,340
+1,454
| +2% | +$111K | 1.7% | 8 |
|
|
2017
Q2 | $6.95M | Buy |
95,886
+223
| +0.2% | +$15K | 1.47% | 13 |
|
|
2017
Q1 | $6.23M | Buy |
95,663
+7,645
| +9% | +$481K | 1.36% | 18 |
|
|
2016
Q4 | $5.51M | Sell |
88,018
-6,355
| -7% | -$388K | 1.32% | 25 |
|
|
2016
Q3 | $5.95M | Sell |
94,373
-1,501
| -2% | -$97.2K | 1.4% | 25 |
|
|
2016
Q2 | $5.94M | Sell |
95,874
-8,742
| -8% | -$533K | 1.38% | 24 |
|
|
2016
Q1 | $5.98M | Buy |
+104,616
| New | +$5.83M | 1.26% | 33 |
|
|
2015
Q3 | – | Sell |
-3,564
| Closed | -$239K | – | 186 |
|
|
2015
Q2 | $239K | Buy |
+3,564
| New | +$233K | 0.06% | 159 |
|
Other funds holding ABBV
Signet Financial Management's ABBV Position: Q1 2026 in Review
Signet Financial Management reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $108K and leaving 24,722 shares worth $5.38M. The position accounts for 0.6% of the portfolio, ranked #51.
Signet Financial Management first reported a position in ABBV in Q2 2015 and has held it in 42 quarters since. The position peaked at $9.28M in Q4 2017. 4,098 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Signet Financial Management held 24,722 shares of AbbVie worth $5.38M as of Q1 2026.
- Signet Financial Management sold 488 AbbVie shares in Q1 2026, an estimated $108K.
- AbbVie made up 0.6% of Signet Financial Management's portfolio in Q1 2026, its #51 holding.
- Signet Financial Management first reported a position in AbbVie in Q2 2015 and has held it in 42 quarters since.
- Signet Financial Management's AbbVie position peaked at $9.28M in Q4 2017.
- 4,098 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.